Evidence map›Paper›PMID 30804750›Full record

ArticleFrontiers in molecular neuroscience2019

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson's Disease.

Christelle Lasbleiz, Nadine Mestre-Francés, Gina Devau, Maria-Rosario Luquin, Liliane Tenenbaum, Eric J Kremer, Jean-Michel Verdier

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Parkinson's Disease: Exploring Different Animal Model Systems.International journal of molecular sciences · 2023
    Review
  2. Article
  3. Article
  4. Zoological research · 2021
    Article
  5. CAV-2-Mediated GFP and LRRK2Frontiers in molecular neuroscience · 2020
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Christelle LasbleizMMDN, University of Montpellier, EPHE, INSERM, U1198, PSL University, Montpellier, France.
Nadine Mestre-FrancésMMDN, University of Montpellier, EPHE, INSERM, U1198, PSL University, Montpellier, France.
Gina DevauMMDN, University of Montpellier, EPHE, INSERM, U1198, PSL University, Montpellier, France.
Maria-Rosario LuquinDepartment of Neurology, Clinica Universidad de Navarra, Pamplona, Spain.
Liliane TenenbaumLaboratory of Molecular Neurotherapies and NeuroModulation, Clinical Neuroscience Department, Lausanne University Hospital, Lausanne, Switzerland.
Eric J KremerInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Jean-Michel VerdierMMDN, University of Montpellier, EPHE, INSERM, U1198, PSL University, Montpellier, France.
École Pratique des Hautes Études · FRInserm · FRCentre National de la Recherche Scientifique · FRClinica Universidad de Navarra · ESUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive CNS disorder that is primarily associated with impaired movement. PD develops over decades and is linked to the gradual loss of dopamine delivery to the striatum,

Indexed as

CAV vectorsdopaminergic neuronsgene transferParkinson’s diseaseprimate

Identifiers

PMID30804750
PMCPMC6378268
OpenAlexW2913461215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.